Literature DB >> 21050726

Dopamine and serotonin transporter availability in chronic heroin users: a [¹²³I]β-CIT SPECT imaging study.

Kelly P Cosgrove1, Karen Tellez-Jacques, Brian Pittman, Ismene Petrakis, Ronald M Baldwin, Gilles Tamagnan, John Seibyl, Thomas Kosten, Julie K Staley.   

Abstract

Dopamine (DA) and serotonin (5-HT) transporter availability in heroin users and healthy controls was measured using [¹²³I]β-CIT and SPECT imaging. Heroin users had statistically similar striatal DA and brainstem and diencephalon 5-HT transporter availability compared with controls. No associations between transporter availability and heroin use characteristics were found.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21050726      PMCID： PMC3011945          DOI： 10.1016/j.pscychresns.2010.08.001

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN： 0165-1781            Impact factor:   3.222


  24 in total

1.  Association between heroin dependence and 5-HT2A receptor gene polymorphisms.

Authors:  P A Sáiz; M P García-Portilla; C Arango; B Morales; S Martínez-Barrondo; C Alvarez; G San Narciso; E Carreño; V Alvarez; E Coto; J Bobes
Journal:  Eur Addict Res       Date:  2008-01-07       Impact factor: 3.015

2.  Regional distribution of serotonergic pre- and postsynaptic markers in human brain.

Authors:  M Laruelle; J M Maloteaux
Journal:  Acta Psychiatr Scand Suppl       Date:  1989

3.  Changes of serotonin and dopamine metabolism in various forebrain areas of rats injected with morphine either systemically or in the raphe nuclei dorsalis and medianus.

Authors:  U Spampinato; E Esposito; S Romandini; R Samanin
Journal:  Brain Res       Date:  1985-02-25       Impact factor: 3.252

4.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

5.  Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites.

Authors:  M Laruelle; M A Vanisberg; J M Maloteaux
Journal:  Biol Psychiatry       Date:  1988-07       Impact factor: 13.382

6.  Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.

Authors:  J K Staley; S Krishnan-Sarin; S Zoghbi; G Tamagnan; M Fujita; J P Seibyl; P K Maciejewski; S O'Malley; R B Innis
Journal:  Synapse       Date:  2001-09-15       Impact factor: 2.562

7.  SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

Authors:  M Laruelle; R M Baldwin; R T Malison; Y Zea-Ponce; S S Zoghbi; M S al-Tikriti; E H Sybirska; R C Zimmermann; G Wisniewski; J L Neumeyer
Journal:  Synapse       Date:  1993-04       Impact factor: 2.562

8.  Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI.

Authors:  R M Baldwin; Y Zea-Ponce; S S Zoghbi; M Laurelle; M S al-Tikriti; E H Sybirska; R T Malison; J L Neumeyer; R A Milius; S Wang
Journal:  Nucl Med Biol       Date:  1993-07       Impact factor: 2.408

9.  Dopamine receptor subsensitivity in the substantia nigra after chronic morphine treatment in rats.

Authors:  U Spampinato; H Gozlan; G Daval; C M Fattaccini; M Hamon
Journal:  Eur J Pharmacol       Date:  1988-05-20       Impact factor: 4.432

10.  High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue.

Authors:  I Bäckström; M Bergström; J Marcusson
Journal:  Brain Res       Date:  1989-05-08       Impact factor: 3.252
View more
  11 in total

1.  Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study.

Authors:  Tzung Lieh Yeh; Kao Chin Chen; Shih-Hsien Lin; I Hui Lee; Po See Chen; Wei Jen Yao; Sheng-Yu Lee; Yen Kuang Yang; Ru-Band Lu; Mei-Hsiu Liao; Nan-Tsing Chiu
Journal:  Psychopharmacology (Berl)       Date:  2011-09-01       Impact factor: 4.530

2.  Longitudinal changes of dopamine transporters in heroin users during abstinence.

Authors:  Shasha Xu; Ying Liu; Yu Li; Yangping Deng; Yiyun Huang; Jie Yuan; Rongbin Lv; Yuankai Wang; Guangming Zhang; Zhirui Guo; Mei Han; Xingdang Liu; Daxu Fu
Journal:  Psychopharmacology (Berl)       Date:  2015-06-23       Impact factor: 4.530

3.  Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies.

Authors:  Felicia Kamp; Lisa Proebstl; Nora Penzel; Kristina Adorjan; Andrej Ilankovic; Oliver Pogarell; Gabi Koller; Michael Soyka; Peter Falkai; Nikolaos Koutsouleris; Joseph Kambeitz
Journal:  Neuropsychopharmacology       Date:  2018-08-27       Impact factor: 7.853

4.  Serotonin transporter protein in autopsied brain of chronic users of cocaine.

Authors:  Junchao Tong; Jeffrey H Meyer; Isabelle Boileau; Lee-Cyn Ang; Paul J Fletcher; Yoshiaki Furukawa; Stephen J Kish
Journal:  Psychopharmacology (Berl)       Date:  2020-06-03       Impact factor: 4.530

5.  Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment.

Authors:  Ying Liu; Mei Han; Xingdang Liu; Yanping Deng; Yu Li; Jie Yuan; Rongbin Lv; Yuankai Wang; Guangming Zhang; Jinlong Gao
Journal:  Psychopharmacology (Berl)       Date:  2013-05-29       Impact factor: 4.530

6.  Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitution.

Authors:  A Schmidt; N Denier; S Magon; E-W Radue; C G Huber; A Riecher-Rossler; G A Wiesbeck; U E Lang; S Borgwardt; M Walter
Journal:  Transl Psychiatry       Date:  2015-03-24       Impact factor: 6.222

Review 7.  Serotonin and mental disorders: a concise review on molecular neuroimaging evidence.

Authors:  Shih-Hsien Lin; Lan-Ting Lee; Yen Kuang Yang
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-12-26       Impact factor: 2.582

8.  Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients.

Authors:  Eline R Zaaijer; Lonneke van Dijk; Kora de Bruin; Anna E Goudriaan; Laureen A Lammers; Maarten W J Koeter; Wim van den Brink; Jan Booij
Journal:  Psychopharmacology (Berl)       Date:  2015-03-12       Impact factor: 4.530

9.  Association between serotonin transporter gene polymorphisms and heroin dependence: a meta-analytic study.

Authors:  Pao-Yen Lin; Yi-Shan Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2016-11-30       Impact factor: 2.570

10.  Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional Clinician Improving Focus, Motivation and Overall Sensory Input Following Chronic Intake.

Authors:  Lucien L Duquette; Frank Mattiace; Kenneth Blum; Roger L Waite; Teresa Boland; Thomas McLaughlin; Kristina Dushaj; Marcelo Febo; Rajendra D Badgaiyan
Journal:  Clin Med Rev Case Rep       Date:  2016-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.